NOVARTIS VENTURE FUND
Our primary focus is on the development of novel therapeutics and platforms. We balance the therapeutic focus with investments in medical devices, diagnostics or drug delivery systems. In our investments we look for unmet need and clinical impact, novel proprietary science and understanding of mechanism, management and board experience and capital efficiency in the program. We prefer to have our initial investment at the early stage to build the company and follow with additional investment ... in pace with the company:tm:s progress. We continue our approach of larger focused investments and anticipate total investments up to USD 30 to 50 mio per company over its life, but it can be as little as 100'000 USD to get started. We will increase our activities to lead or co-lead deals further and remain open to participate in larger syndicates. Sectors New therapeutics & platforms Medical devices/implants Diagnostics/biomarkers Drug delivery/biopolymers Geography USA/Canada Europe Switzerland Asia/Pacific
NOVARTIS VENTURE FUND
Industry:
Finance Therapeutics Venture Capital
Founded:
1996-01-01
Status:
Active
Contact:
877 280 2296
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Universal Analytics DigiCert SSL GlobalSign Domain Verification Proofpoint Imperva Bot Detection And Mitigation
Similar Organizations
ABB Technology Ventures
ABB Technology Ventures (ATV) is the strategic venture capital unit of ABB (NYSE: ABB).
ALSA Ventures
ALSA Ventures invest in biotechnology companies passionate about bringing novel therapies to patients.
BB Biotech Ventures
BB BIOTECH VENTURES is a healthcare-dedicated venture capital fund, focused on companies that develop and market drugs and medical devices.
Civilization Ventures
Civilization Ventures is a venture capital firm focused on cutting edge innovations in exponential health tech and biology.
Claris Ventures
Claris Ventures is a venture capital firm focused on early-stage investments in high potential biopharma companies.
Digitalis Ventures
Digitalis is a venture capital firm that that invests in solutions to complex problems in human and animal health.
EIR Ventures
EIR Ventures is a new Life Science Venture Group in the Nordics.
Forward Ventures
Forward Ventures ic a venture capital company that focuses in companies in the area of biological sciences.
Founders Fund
Founders Fund is a venture capital firm investing in companies building revolutionary technologies.
Hikma Ventures
Hikma Ventures operates as the corporate venture capital arm of Hikma Pharmaceuticals.
Kibo Ventures
Kibo Ventures is a venture capital fund investing in early-stage internet and mobile companies.
LocalGlobe
LocalGlobe is a venture capital firm that focuses on seed and impact investments.
Novalis LifeSciences
Novalis Lifesciences is a globally acting venture capital firm focused on breakthrough technologies in Life Science.
Roche Venture Fund
The Roche Venture Fund is the name given to the corporate venture fund of the healthcare company Roche.
Samsung Ventures
Samsung Ventures is a venture capital firm specializing in investments in start-up companies.
TA Ventures
TA Ventures is a VC firm backing ambitious founders of technology companies across Europe, North America and beyond.
Union Square Ventures
Union Square Ventures is a venture capital firm that focuses on early-stage, growth-capital, late-stage, and startup financing.
VentureFriends
VentureFriends is a venture capital fund that invests in tech-enabled companies.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-03-02 | Epsilogen | Novartis Venture Fund investment in Series B - Epsilogen | 30.75 M GBP |
| 2022-02-15 | Splice Bio | Novartis Venture Fund investment in Series A - Splice Bio | 50 M EUR |
| 2022-01-20 | ImmPACT Bio | Novartis Venture Fund investment in Series B - ImmPACT Bio | 111 M USD |
| 2021-12-28 | IKAS Industrial Automation | Novartis Venture Fund investment in Series B - IKAS Industrial Automation | 100 M CNY |
| 2021-12-16 | Anaveon | Novartis Venture Fund investment in Series B - Anaveon | 110 M CHF |
| 2021-11-23 | LOQUS23 THERAPEUTICS | Novartis Venture Fund investment in Seed Round - LOQUS23 THERAPEUTICS | 7 M GBP |
| 2021-11-15 | Kedalion Therapeutics | Novartis Venture Fund investment in Series B - Kedalion Therapeutics | N/A |
| 2021-10-05 | Exo Therapeutics | Novartis Venture Fund investment in Series B - Exo Therapeutics | 78 M USD |
| 2021-09-29 | Expansion Therapeutics | Novartis Venture Fund investment in Series B - Expansion Therapeutics | 80 M USD |
| 2021-09-15 | Flywheel.io | Novartis Venture Fund investment in Series C - Flywheel.io | 22 M USD |
More informations about "Novartis Venture Fund"
About Us | Novartis Venture Fund
We’re investing in the future health of patients worldwide. The Novartis Venture Fund was created to foster innovation, drive significant patient benefit, and generate superior returns by nurturing and investing in innovative life science companies.See details»
Biopharma/Biotech Investment | Novartis Venture Fund
Currently managing approximately USD 750 million, our life science venture fund is strategically positioned to make impactful equity investments in pioneering biotechnology and …See details»
Novartis Venture Fund - Crunchbase Investor Profile
Novartis Venture Fund invests in early to late-stage biotechnology and healthcare companies, focusing on therapeutics. Their investment strategy spans North America and Europe, with key locations in Cambridge, San Diego, and London.See details»
Novartis Venture Fund Team - nvfund.com
The Novartis Venture Fund Team is made up of people with proven expertise and talent in bringing exciting new drugs and treatments to patients all over the world.See details»
Novartis Venture Fund - Investments, Portfolio & Company Exits
Sep 9, 2020 · Novartis Venture Fund is a venture capital firm focused on companies that develop novel therapeutics and platforms.See details»
Novartis Venture Fund Portfolio Companies - Crunchbase
Novartis Venture Fund is a venture capital firm focused on companies that develop novel therapeutics and platforms. This list of organizations invested in by Novartis Venture Fund …See details»
Novartis Venture Fund (NVF) - Life-Sciences-Europe.com
Jan 1, 1996 · The Novartis Venture Funds, established in 1996 currently manage over $750 million in committed capital. NVF invests in companies which have the potential to change a …See details»
Novartis Venture Fund - Private Equity International
Founded in 1996, Novartis Venture Fund is a Switzerland based investment organisation that focuses on the healthcare sector, develops novel therapeutics and platforms.See details»
Novartis Venture Fund investment portfolio | PitchBook
Jul 17, 2024 · Founded in 1996, Novartis Venture Fund is a corporate venture capital arm of Novartis and is based in Basel, Switzerland.See details»
Our pharma portfolio strategy | Novartis Venture Fund
The Novartis Venture Fund invests in over 40 life sciences companies across the world with a portfolio model focused on biotechnology and biopharma.See details»
Novartis Venture Fund - Org Chart, Teams, Culture & Jobs - The Org
View Novartis Venture Fund's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Novartis Venture Fund - EU-Startups
Novartis Venture Fund's primary focus is on the development of novel therapeutics and platforms. They balance the therapeutic focus with investments in medical devices, diagnostics, or drug …See details»
Novartis Venture Fund | Investors | Mindmaps
Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet …See details»
Our Successes | Novartis Venture Fund - nvfund.com
The Novartis Venture Fund invests in life science companies with products that answer unmet clinical needs, achieving successful exits including IPOs, mergers and acquisitions, and FDA …See details»
Novartis Venture Fund - Funding, Financials, Valuation & Investors
Novartis Venture Fund is a venture capital firm focused on companies that develop novel therapeutics and platforms.See details»
Novartis Venture Fund: Performance - PitchBook
Sep 18, 2017 · Novartis Venture Fund was a venture capital fund managed by Novartis Venture Fund. The fund was located in Basel, Switzerland and invested in Europe, North America and …See details»
Meet Aaron Nelson | Novartis Venture Fund - nvfund.com
Aaron Nelson MD, PhD is a Managing Director at the Novartis Venture Fund in Cambridge, MA, USA. Prior to NVF, he was an investor at dRx Capital, a joint investment company of Novartis …See details»
Novartis Venture Fund Company Profile - Craft
See insights on Novartis Venture Fund including office locations, executives, portfolio, news, trends and more.See details»
IPO | Novartis Venture Fund - nvfund.com
The Novartis Venture Fund team develops exit strategies that help guide life science companies working in biotechnology and biopharmaceuticals to successful initial public offering (IPO) exits.See details»
Novartis Venture Fund - Contacts, Employees, Board Members
Novartis Venture Fund is a venture capital firm focused on companies that develop novel therapeutics and platforms.See details»